Résultats de recherche
Sans surprise, les thérapies ciblées et l’immunothérapie sont toujours les invitées d’honneur pour cette édition du congrès de l’Asco. Dans le cancer bronchopulmonaire en particulier, les évolutions majeures entreprises ces dernières années se traduisent concrètement, avec une amélioration notable du devenir des patients.
Il y a 8 heures · Mutations and prognosis of KDELR family genes. We analyzed genomic alterations of the KDELR family in 3513 LUAD patients across ten studies and assessed their associations with OS and disease-free ...
Il y a 8 heures · EGFR mutations are significantly more common than other molecular targets, however, even for them the progress towards adjuvant therapy approval has taken more than a decade . Relevant investigations on other LC-associated molecular events are more problematic. For the time being, the results of adjuvant alectinib study in
Il y a 8 heures · In recent decades, the field of systemic cancer treatment has seen remarkable changes due to advancements in the understanding of cancer’s biology, immunology, and genetic makeup. As a result, individuals with late-stage cancers are now achieving survival rates that were previously unattainable. The goal of personalized cancer therapy is to enhance clinical outcomes by customizing drug ...
Il y a 8 heures · À Thionville, certains quartiers subissent des mutations plus spectaculaires que d’autres. C’est le cas de Beauregard qui, en plus de gagner de nouveaux habitants dans les constructions ...
Il y a 8 heures · La 30e édition des Universités d'été portera sur les Héritages et mutations dans l'entrepreneuriat. Entre intelligence artificielle, décroissance et sens au travail : les chefs d'entreprise seront accompagnés dans ces bouleversements.
Il y a 8 heures · Whilst we are aware that specific mutations are able to drive the disorders, we do not understand how such events result in a multitude of tissues being affected at different times in life, nor why clinical disease often follows distinct patterns across different patients. We hope that our genomics research at the Sanger Institute will shed light on the origin and trajectory of these diseases ...
